Dexin Corporation
Dexin Corporation engages in the design, development, engineering, manufacture, and sale of entertainment interface devices in Taiwan and internationally. The company offers esports peripherals, such as e-sports mouse, controllers, keyboards, and gaming mouse pad, as well as stylus; and optical products comprising camera modules, vehicle camera modules and media cameras. It also is involved in th… Read more
Dexin Corporation (3349) - Total Liabilities
Latest total liabilities as of September 2025: NT$234.28 Million TWD
Based on the latest financial reports, Dexin Corporation (3349) has total liabilities worth NT$234.28 Million TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dexin Corporation - Total Liabilities Trend (2019–2024)
This chart illustrates how Dexin Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dexin Corporation Competitors by Total Liabilities
The table below lists competitors of Dexin Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Teract S.A.
PA:TRACT
|
France | €886.50 Million |
|
EON Resources Inc.
NYSE MKT:EONR
|
USA | $28.62 Million |
|
Green Critical Minerals Ltd
AU:GCM
|
Australia | AU$592.06K |
|
Lian Fa International Dining Business Corp.
TWO:2756
|
Taiwan | NT$775.80 Million |
|
Marygold Companies Inc
NYSE MKT:MGLD
|
USA | $5.11 Million |
|
Trinity Biotech plc
NASDAQ:TRIB
|
USA | $158.43 Million |
|
Elevation Oncology Inc
NASDAQ:ELEV
|
USA | $35.49 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Dexin Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dexin Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dexin Corporation (2019–2024)
The table below shows the annual total liabilities of Dexin Corporation from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$259.39 Million | +6.50% |
| 2023-12-31 | NT$243.56 Million | -33.22% |
| 2022-12-31 | NT$364.70 Million | -8.70% |
| 2021-12-31 | NT$399.44 Million | -25.27% |
| 2020-12-31 | NT$534.50 Million | +221.02% |
| 2019-12-31 | NT$166.50 Million | -- |